Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes

January 2008
BMC Genetics;2008, Vol. 9, p299
Academic Journal
No abstract available.


Related Articles

  • Gene expression profiling separates chronic myelomonocytic leukemia in two molecular subtypes. Gelsi-Boyer, V.; Cervera, N.; Bertucci, F.; Trouplin, V.; Remy, V.; Olschwang, S.; Chaffanet, M.; Vey, N.; Mozziconacci, M.-J.; Birnbaum, D. // Leukemia (08876924);Nov2007, Vol. 21 Issue 11, p2359 

    A letter to the editor is presented in response to the article "Gene expression profiling separates chronic myelomonocytic leukemia in two molecular subtypes ," published in the previous issue.

  • Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies. Gómez-Seguí, I; Makishima, H; Jerez, A; Yoshida, K; Przychodzen, B; Miyano, S; Shiraishi, Y; Husseinzadeh, H D; Guinta, K; Clemente, M; Hosono, N; McDevitt, M A; Moliterno, A R; Sekeres, M A; Ogawa, S; Maciejewski, J P // Leukemia (08876924);Sep2013, Vol. 27 Issue 9, p1943 

    A letter to the editor is presented regarding the discovery of somatic mutations in RIT1 gene of chronic myelomonocytic leukemia (CMML) patients.

  • Calreticulin mutations are not present in patients with myeloproliferative chronic myelomonocytic leukemia. Zamora, Lurdes; Germing, Ulrich; Cabezón, Marta; Schuler, Esther; Arnan, Montserrat; Marcé, Silvia; Coll, Rosa; Pomares, Helena; Brings, Carolin; Palomo, Laura; Schmeneau, Jennifer; Gallardo, David; Millá, Fuensanta; Feliu, Evarist; Xicoy, Blanca // Annals of Hematology;May2015, Vol. 94 Issue 5, p869 

    A letter to the editor is presented on a study which CALR gene mutations in chronic myelomonocytic leukemia.

  • Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance. Grossmann, V.; Kohlmann, A.; Eder, C.; Haferlach, C.; Kern, W.; Cross, N. C. P.; Haferlach, T.; Schnittger, S. // Leukemia (08876924);May2011, Vol. 25 Issue 5, p877 

    A letter to the editor is presented regarding the study on the mutations of genes and cytogenetics in molecular writing of the patients with chronic myelomonocytic leukemia (CMML).

  • Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Mead, Adam // Current Medical Literature: Leukemia & Lymphoma;2013, Vol. 21 Issue 3, p86 

    The article discusses research which explored broader genomic landscape in juvenile myelomonocytic leukemia (JMML) using a whole exome sequencing approach. It references a study by H. Sakaguchi et al, published in a 2013 issue of the journal "Natural Genetics." It presents a contrast between...

  • Runx1 Loss Minimally Impacts Long-Term Hematopoietic Stem Cells. Cai, Xiongwei; Gaudet, Justin J.; Mangan, James K.; Chen, Michael J.; Obaldia, Maria Elena De; Oo, Zaw; Ernst, Patricia; Speck, Nancy A. // PLoS ONE;2011, Vol. 6 Issue 12, p1 

    RUNX1 encodes a DNA binding subunit of the core-binding transcription factors and is frequently mutated in acute leukemia, therapy-related leukemia, myelodysplastic syndrome, and chronic myelomonocytic leukemia. Mutations in RUNX1 are thought to confer upon hematopoietic stem cells (HSCs) a...

  • Myeloid malignancies: mutations, models and management. Murati, Anne; Brecqueville, Mandy; Devillier, Raynier; Mozziconacci, Marie-Joelle; Gelsi-Boyer, V�ronique; Birnbaum, Daniel // BMC Cancer;2012, Vol. 12 Issue 1, p304 

    Myeloid malignant diseases comprise chronic (including myelodysplastic syndromes, myeloproliferative neoplasms and chronic myelomonocytic leukemia) and acute (acute myeloid leukemia) stages. They are clonal diseases arising in hematopoietic stem or progenitor cells. Mutations responsible for...

  • Meningeal involvement of chronic myelomonocytic leukemia. Aoyama, Koji; Ishikura, Hiroto; Tsumura, Hiroto; Watanabe, Tatsuzo; Suyama, Nobuo; Kumakura, Shunnichi; Kobayashi, Shotai // Journal of Neurology;Aug2003, Vol. 250 Issue 8, p993 

    Presents a letter to the editor which focuses on the meningeal involvement of chronic myelomonocytic leukemia.

  • Management of patient with CMML-2 and confounding symptoms. Wood, William // Hem/Onc Today;10/25/2010, Vol. 11 Issue 20, p32 

    The author addresses the management of patient diagnosed with chronic myelomonocytic leukemia (CCML-1).

  • Acquired factor XIII deficiency with chronic myelomonocytic leukemia. Petri, Michelle; Ellman, Leonard; Carey, Robert; Petri, M; Ellman, L; Carey, R // Annals of Internal Medicine;Nov83, Vol. 99 Issue 5, p638 

    Presents a case of acquired factor XIII deficiency with chronic myelomonocytic leukemia. Manifestations of the disease; Characteristics of chronic myelomonocytic leukemia; Bleeding complications.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics